TZ9, CAS 1002789-86-7

TZ9, CAS 1002789-86-7, Stock 273g, Assay 99.7%, White powder, Water 0.27%, Single Impurity 0.3%.

TZ9

TZ9 is an inhibitor of Rad6B expressing human breast cancer cell lines MDA-MB-231 and MCF-7. It is also the first competitive E2-ligase inhibitor that acts by blocking thioester formation.

Product Details:

Name: TZ9

CAS#: 1002789-86-7

Chemical Formula: C17H14N6O4

Exact Mass: 366.1077

Molecular Weight: 366.33

Elemental Analysis: C, 55.74; H, 3.85; N, 22.94; O, 17.47

Specification:

Synonym: TZ9; TZ-9; TZ 9; SMI#9;

IUPAC/Chemical Name: (4-Amino-6-anilino-1,3,5-triazin-2-yl)methyl 4-nitrobenzoate

InChi Key: RRRDZFQRNJTKHL-UHFFFAOYSA-N

InChi Code: InChI=1S/C17H14N6O4/c18-16-20-14(21-17(22-16)19-12-4-2-1-3-5-12)10-27-15(24)11-6-8-13(9-7-11)23(25)26/h1-9H,10H2,(H3,18,19,20,21,22)

SMILES Code: O=C(OCC1=NC(N)=NC(NC2=CC=CC=C2)=N1)C3=CC=C([N+]([O-])=O)C=C3

Appearance: Solid powder

Purity: >99% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

Certification: